NOTCH2 and intrahepatic cholangiocarcinoma: Furthermore, analysis of the cBioPortal for Cancer Genomics dataset [39] revealed Notch2 amplification in 4/36 (11%) human ICC specimens, whereas no alterations were identified for Notch1 (Sup Fig. 5C).